On Thursday, March 31st, the US House of Representatives voted to pass a $35 insulin copay cap. The bill now heads to the Senate. While a $35 copay cap on insulin would impact many people, T1International is calling on the Senate to pass a true price cap on insulin for everyone, especially those without insurance. Read more
For some, the first 100 years of insulin has been a great, life-affirming success. For others, it has been a failure, where leaders and organizations in power have chosen profits over the lives and welfare of human beings. So how will we shape the next 100 years? Read more
More and more organisations today, from NGOs to global health alliances, are expressing a need for patient engagement and claiming to be patient-informed. As a patient-led organisation, we have noted that patient engagement is often well-intentioned but misguided. While patients might be acknowledged as experts on an event flyer or web page, that expert status does not necessarily mean they are compensated equitably or that their perspectives are valued and/or integrated comparably to other accepted experts, such as physicians or academic researchers. Read more
Established in 2021, the T1International Zimbabwe #insulin4all Chapter, led by Global Chapter Representative Laura Munyoro, has made significant strides in developing the structure of their advocacy network and taking action as community leaders. Read more
Another year of challenges and outrage, another year of incredible advocacy by our T1International Community! For 2021, we’ve decided to create a Top 10 list of some of our biggest collective achievements. Read more
T1International is proud to join T1International’s Minnesota #insulin4all Chapter and patient advocates at the oral argument before the United States Court of Appeals for the Eighth Circuit (Eighth Circuit) in support of upholding Minnesota’s Alec Smith Insulin Affordability Act (Alec’s Law) on December 15, 2021. Read more
JohnPeter exemplifies the resilient spirit and patient perseverance that any lifelong advocate must have. He says, ''Being a Global Advocate with T1International has taught me the resilience to fight for what I believe in.'' Read more
In September 2021, T1International’s latest out-of-pocket cost survey was published in the Journal of Diabetes Research and Clinical Practice. Conducted every two years, this study is the most comprehensive patient-led out-of-pocket cost survey for people living with type 1 diabetes. Read more
T1International’s global community of people living with and affected by diabetes and their allies celebrates a monumental advocacy win as the World Health Organization announced the addition of long-acting insulin analogues to the Model List of Essential medicines (EML). Read more
Join us for T1International’s annual #insulin4all Workshop: Advocate, Don’t Celebrate. This event is an opportunity for advocates from around the world to learn from each other, build community, and take action in the fight for #insulin4all. Read more